- Datum02.09.2026
- Uhrzeit12:00 - 13:00 Uhr
- Veranstalter
stock3
Zentalis Pharmaceuticals Inc. Chart inkl. Chartanalyse

Charts analysieren
wie die Profis?
Nutze unser Profi-Charting-Tool für Deine eigenen Analysen

Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| Nasdaq | VK | |||||
| Nasdaq Basic | VK | |||||
| Cboe BZX | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Wertentwicklung (Nasdaq)
Passender Service zu Zentalis Pharmaceuticals Inc.
Webinar zu Zentalis Pharmaceuticals Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)1,212-6,950
- Jahrestief / Hoch ($)1,320-6,950
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Zentalis Pharmaceuticals Inc.
Termine von Zentalis Pharmaceuticals Inc.
- Nov11Zentalis Pharmaceuticals Inc.Q3 2026 Earnings Release
- Mai12Zentalis Pharmaceuticals Inc.Q1 2027 Earnings Release
Beschreibung
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.
